RenovoRx, Inc.
RNXT
$0.972
-$0.018-1.82%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.71% | -21.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.41% | -6.79% | |||
| Operating Income | 6.93% | 6.79% | |||
| Income Before Tax | -16.47% | -3.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.47% | -3.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.47% | -3.43% | |||
| EBIT | 6.93% | 6.79% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -15.64% | 0.20% | |||
| Normalized Basic EPS | -15.67% | 0.32% | |||
| EPS Diluted | -15.64% | 0.20% | |||
| Normalized Diluted EPS | -15.67% | 0.32% | |||
| Average Basic Shares Outstanding | 0.67% | 3.71% | |||
| Average Diluted Shares Outstanding | 0.67% | 3.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||